bioAffinity Technologies, Inc. SEC filings BIAFW
bioAffinity Technologies, Inc. has 399 filings in SEC EDGAR's recent list, going back to Jul 26, 2017. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 1, 2025 | — |
| 3 | Initial insider ownership | Sep 25, 2025 | Aug 12, 2025 |
| 3 | Initial insider ownership | Sep 25, 2025 | Aug 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2025 | — |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 5, 2024 |
| 3 | Initial insider ownership | Sep 20, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 12, 2024 |
| 4 | Insider transaction | Apr 24, 2024 | Apr 8, 2024 |
| 4 | Insider transaction | Apr 24, 2024 | Apr 4, 2024 |
| 4 | Insider transaction | Apr 24, 2024 | Apr 3, 2024 |
| 4 | Insider transaction | Mar 29, 2024 | Feb 16, 2024 |
| 4 | Insider transaction | Mar 29, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Oct 1, 2023 |
| 4 | Insider transaction | Jan 24, 2024 | Oct 1, 2023 |
| 4 | Insider transaction | Jan 24, 2024 | Oct 1, 2023 |
| 4 | Insider transaction | Jan 24, 2024 | Oct 1, 2023 |
| 4 | Insider transaction | Jan 24, 2024 | Oct 1, 2023 |
| 4 | Insider transaction | Jan 24, 2024 | Oct 1, 2023 |
| 4 | Insider transaction | Jan 24, 2024 | Oct 1, 2023 |
| 4 | Insider transaction | Jan 24, 2024 | Oct 1, 2023 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 1, 2024 |
| 3 | Initial insider ownership | Dec 8, 2023 | Dec 1, 2023 |
| SC 13G | Ownership over 5% (passive) | Oct 10, 2023 | — |
| 3 | Initial insider ownership | Sep 26, 2023 | Sep 18, 2023 |
| 3 | Initial insider ownership | Sep 25, 2023 | Sep 18, 2023 |
| 4 | Insider transaction | Aug 11, 2023 | Jan 1, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jan 1, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jan 1, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jan 1, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jan 1, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jan 1, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jan 1, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jun 6, 2023 |
| 4 | Insider transaction | Jul 6, 2023 | Jan 1, 2023 |
| 3 | Initial insider ownership | May 11, 2023 | May 1, 2023 |
| 4 | Insider transaction | Mar 7, 2023 | Sep 6, 2022 |
| 3 | Initial insider ownership | Mar 7, 2023 | Aug 29, 2022 |
| 4 | Insider transaction | Mar 7, 2023 | Sep 6, 2022 |
| 3 | Initial insider ownership | Mar 7, 2023 | Aug 29, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Nov 17, 2022 |
| 3 | Initial insider ownership | Dec 5, 2022 | Aug 29, 2022 |
| 4 | Insider transaction | Dec 5, 2022 | Aug 31, 2022 |
| 3 | Initial insider ownership | Dec 5, 2022 | Aug 29, 2022 |
| 4 | Insider transaction | Dec 2, 2022 | Aug 31, 2022 |
| 3 | Initial insider ownership | Dec 2, 2022 | Aug 29, 2022 |
| 4 | Insider transaction | Dec 2, 2022 | Aug 31, 2022 |
| 3 | Initial insider ownership | Dec 2, 2022 | Aug 29, 2022 |
| 4 | Insider transaction | Nov 29, 2022 | Sep 1, 2022 |
| 3 | Initial insider ownership | Nov 29, 2022 | Aug 29, 2022 |
| 4 | Insider transaction | Nov 22, 2022 | Nov 17, 2022 |
| 3 | Initial insider ownership | Nov 22, 2022 | Aug 29, 2022 |
| 4 | Insider transaction | Nov 22, 2022 | Aug 31, 2022 |
| 3 | Initial insider ownership | Nov 22, 2022 | Aug 29, 2022 |
| 4 | Insider transaction | Nov 8, 2022 | Aug 31, 2022 |
| 3 | Initial insider ownership | Nov 8, 2022 | Aug 29, 2022 |
| 4 | Insider transaction | Oct 21, 2022 | Aug 31, 2022 |
| 3 | Initial insider ownership | Oct 21, 2022 | Aug 29, 2022 |
Showing 83 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Commercial Physical & Biological Research (SIC 8731)
- Listed as
- BIAF (Nasdaq), BIAFW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Antonio, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1712762
- Former names
- bioAffinity Technologies, Inc. (until Nov 3, 2026)
Other Services-Commercial Physical & Biological Research companies
- Iqvia Holdings Inc. IQV
- Incyte Corp INCY
- Medpace Holdings, Inc. MEDP
- Charles River Laboratories International, Inc. CRL
- Icon PLC ICLR
- Absci Corp ABSI
- OmniAb, Inc. OABI
- NRC Health NRC
All 17 Services-Commercial Physical & Biological Research companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.